International Biotechnology Trust

International Biotechnology Trust offers investors access to the fast growing biotechnology sector through an actively managed fund.

Business Model:

Revenue: $0

Employees: 0-0

Rankings

Detailed International Biotechnology Trust Information

Geographic Data

International Biotechnology Trust headquarters map

Address: 71 Kingsway

City: London

State: england

Zip: WC2B 6ST

Country: GB

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

4,989,529Website Global Rank

1,949Website Monthly Traffic

Twitter Followers

Description

International Biotechnology Trust offers investors access to the fast growing biotechnology sector through an actively managed, diversified fund. Its award winning fund managers at SV Health Investors are scientifically and medically trained with over 60 years of experience in this specialist sector between them. As well as investing in a wide ranging portfolio of global quoted biotechnology stocks, they include a small proportion of otherwise inaccessible carefully selected unquoted investments which have the potential to deliver additional returns over the long term. Excellent management teams, unique innovative products and strong potential for outperformance are the key criteria for inclusion in their diversified portfolio of assets. International Biotechnology Trust offers investors the rare combination of high capital growth and sustainable dividend income. The Lead Investment Manager, Carl Harald Janson is celebrating his five year tenure with strong performance versus the benchmark, significantly outperforming the NBI on both a NAV and share price basis, with outperformances of 10.9% and 43.4% respectively. The NAV has also substantially outperformed the FTSE All-Share Index over the same period, with a return of 142.0% vs the index return of 44.1%.

Contact Phone:

Contact Email:

International Biotechnology Trust went public on 1/15/1999 on the LSE

Listed Exchange:
LSE

IPO Date:
1/15/1999

Ticker Symbol:
IBT

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
10/2007 Sutro Biopharma Venture Round 0
5/2005 Oxagen Series B 0
5/2000 eBioinformatics Venture Round 0
10/2001 Aderis Pharmaceuticals Series D 0
9/2012 Karus Therapeutics Series B 7.6M
11/2009 Oxagen Series C 0
10/2005 GlycoFi Inc. Series C 11M
9/2012 Karus Therapeutics Series B 0
11/2009 Oxagen Series C 0
10/2007 Sutro Biopharma Venture Round 0
10/2005 GlycoFi Inc. Series C 0
5/2005 Oxagen Series B 0
10/2001 Aderis Pharmaceuticals Series D 0
5/2000 eBioinformatics Venture Round 0
Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research